Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 182 is a member of the Krueppel C2H2-type zinc finger protein family in humans. It serves as a DNA-binding transcription factor, likely regulating gene expression at the level of RNA polymerase II. While zinc finger proteins as a class are widely implicated in various cellular processes (including transcriptional regulation, development, cell differentiation, and disease), specific biological roles or pathology associations of ZNF182 remain poorly characterized. No evidence currently suggests that ZNF182 is therapeutically targeted or associated with specific drug mechanisms, disease biomarkers, or safety issues[3][6][7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 182 (ZNF182).